Pakistani media agencies losing revenue year on year: research
A RECMA report discloses a worrisome decline in advertising expenditure that all members of Pakistan Broadcasters Association depend on
Stay updated with breaking news from Abecma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A RECMA report discloses a worrisome decline in advertising expenditure that all members of Pakistan Broadcasters Association depend on
The Coast: It’s so hot out! I think I’m going to have ice cream for supper tonight. What’s your favourite ice cream flavour, Rose? Rose Cousins: I'm pretty basic, like, vanilla with some chocolate or a straight-up chocolate. But I wouldn't turn away a praline and cream. It depends on the day. I tend to go back and forth between Moon Mist and Cotton Candy. No! You’re like an eight-year child. [Laughs] Well, it is a love-it-or-hate-it flavour. So, congrats on winning the Juno! Was it exciting to accept an award virtually or was it weird?
May 3, 2021 9:50am Bristol Myers Squibb plans to pilot a virtual reality training program at its upcoming cell therapy plant in Massachusetts—and that's just the tip of the high-tech iceberg. Even as more cell therapies push past the finish line, questions about how to make the personalized medicines swiftly and dependably persist. For Bristol Myers Squibb, which is standing up two new cell factories, automation and high-tech training will form twin jewels in its production crown, an exec said. Making cell therapies such as BMS' recently approved CAR-T meds Breyanzi and Abecma is a high...
Apr 22, 2021 7:00am Bristol Myers Squibb's upcoming cell therapy plant in the Netherlands should help slash turnaround times for patients receiving its CAR-T therapies there. (Bristol Myers Squibb) Right on the heels of not one, but two CAR-T approvals in the U.S., Bristol Myers Squibb is bolstering its commercial cell therapy ambitions on the other side of the Atlantic. The company on Thursday pegged Leiden, Netherlands, as the home of its first cell therapy factory in Europe and its fifth worldwide. With planning for site design and development underway, BMS expects construction to kic...
Electronic musician Lilstiffy back in Whanganui with new album 16 Apr, 2021 05:00 PM 3 minutes to read The Lilstiffy project began in Wellington in 2014. Photo / Supplied Mike Tweed is a multimedia journalist at the Whanganui Chroniclemichael.tweed@nzme.co.nzWhangaChron Electronic musician Lilstiffy has returned to Whanganui from Tokyo and he's brought a new album, Ecma, with him. The Lilstiffy project began in Wellington in 2014, he said. "It started with making beats and working with rappers, and running regular club nights. "I got sick of Wellington and decided to move to...